2020-09-25@20:22:25 GMT
1000 results - (0.004 seconds)

COVID 19 vaccine:

    By Vishwadha Chander (Reuters) - A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published on Friday. The vaccine, called Ad26.COV2.S, was equally well-tolerated at two different doses, the results showed. A single shot, versus a rival two-dose approach being tested by Moderna Inc and Pfizer Inc , could simplify distribution of the vaccine. However, it is unclear whether elderly people, one of the populations most at risk from the virus, will be protected to the same degree as younger people with the J&J vaccine. The trial in close to 1,000 healthy adults, which is backed by the...
    GENEVA/ZURICH (Reuters) - The death toll from the coronavirus could double to 2 million before a successful vaccine is widely used and could be even higher without concerted action to curb the pandemic, an official at the World Health Organization said on Friday. "Unless we do it, all the number you speak about (2 million deaths) is not only imaginable, but sadly very likely," Mike Ryan, head of the WHO emergencies programme, said in a briefing on Friday. His assessment came as the total number of deaths nine months since the virus was discovered in China neared the grim milestone of 1 million. (Reporting by Stephanie Nebenay and Emma Farge in Geneva and Michael Shields in Zurich; Writing by Josephine...
    With nearly 7 million cases of COVID-19 diagnosed, and over 200 thousand lives lost, Americans are desperate for this pandemic to be over. Leading many to beg the question: when will a COVID-19 vaccine be available?     Watch THE DR. OZ SHOW, weekdays at 3 p.m. on CBS 62. Related
    By SAM McNEIL, Associated Press BEIJING (AP) — A Chinese health official said Friday that the country's annual production capacity for coronavirus vaccines will top 1 billion doses next year, following an aggressive government support program for construction of new factories. Capacity is expected to reach 610 million doses by the end of this year, Zheng Zhongwei from the National Health Commission said. “Next year, our annual capacity will reach more than 1 billion doses,” he said at a news conference. American pharmaceutical giants Pfizer and Moderna aim to produce a billion doses each in 2021 as well. Zheng said distribution of the vaccines would prioritize groups such as medical workers, border personnel and the elderly before they are made...
    NEW YORK (CBSNewYork) — New York City is threatening shutdowns after coronavirus spikes in certain neighborhoods. Patrol officers will be making sure people wear masks and social distance, even inspecting some non-public schools. If these neighborhoods don’t get their COVID numbers under control over the weekend, non-essential businesses and schools could be forced to close again. Specific areas include: Gravesend/Homecrest — 6.0% infection rate Midwood — 4.95% infection rate Edgemere/Far Rockaway — 4.08% infection rate Kew Gardens — 3.99% infection rate Borough Park — 3.53% infection rate Other targeted areas include Bensonhurst, Mapleton, Gerritsen Beach, Sheepshead Bay, Flatlands and Williamsburg. “Obviously, I’m scared. New York has done such a wonderful job keeping the numbers down. I feel like...
    BEIJING – A Chinese health official said Friday that the country's annual production capacity for coronavirus vaccines will top 1 billion doses next year, following an aggressive government support program for construction of new factories. Capacity is expected to reach 610 million doses by the end of this year, Zheng Zhongwei from the National Health Commission said. “Next year, our annual capacity will reach more than 1 billion doses,” he said at a news conference. American pharmaceutical giants Pfizer and Moderna aim to produce a billion doses each in 2021 as well. Zheng said distribution of the vaccines would prioritize groups such as medical workers, border personnel and the elderly before they are made available to the general public....
    Sen. Thom Tillis, R-N.C., on Thursday told a virtual town hall audience that he believed the 200,000 deaths attributed to COVID-19 in the U.S. had been inflated in order to “encourage people to use social distancing.” “When the final accounting is done,” the actual COVID-19 death count will be lower, Tillis claimed. The response echoes a false conspiracy theory pushed by adherents of the baseless QAnon movement: that public health officials are allegedly lying to the public about the true death count because of ulterior or possibly sinister motives. Only 6% of the reported deaths are attributable solely to COVID-19, conspiracy theorists claim. Tillis also embraced an extreme anti-vaccine position and appeared to welcome herd immunity as part of a strategy to get 60% of the country immune. (Dr. Anthony Fauci, the...
    MOSCOW (Reuters) - Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil. (Reporting by Anton Kolodyazhnyy; Writing by Polina Ivanova; Editing by Toby Chopra) Copyright 2020...
    (CNN)The US remains in the first wave of the Covid-19 pandemic since cases never declined significantly to a good baseline, says Dr. Anthony Fauci, the nation's leading infectious disease expert. The idea of a second wave is based on the pattern seen during the 1918 pandemic, when cases were seen in the spring and then cases "literally disappeared" before there was an "explosion" of cases in the fall, Fauci said."Rather than say, 'A second wave,' why don't we say, 'Are we prepared for the challenge of the fall and the winter?'" Fauci said. Fauci cautions that a Covid-19 vaccine wont eliminate the need for masks and public health measuresThat challenge could include surges of Covid-19 cases across the country as...
    NEW YORK (CBSNewYork) — Gov. Andrew Cuomo weighed in on the pandemic Thursday, questioning whether the Trump administration will deliver a safe and effective COVID-19 vaccine. The governor says New York state will have its own health officials to screen any federally approved vaccine. “Frankly, I’m not going to trust the federal government’s opinion, and I wouldn’t recommend to New Yorkers based on the federal government’s opinion,” Cuomo said. CORONAVIRUS PANDEMIC Tri-State Coronavirus Travel Advisory Quarantine List Resources, Hotlines, Unemployment & Covering Bills Remote Learning Tools For Parents Teaching At Home CBS2’s Dr. Max Answers Your Health Questions What To Do If Someone Isn’t Social Distancing Or Wearing A Mask? Expert: Parents Be Mindful Of Children’s Stress After Months...
    Vaccine trials need to be representative of the communities at highest risk, Fauci again urged. Speaking at the Bloomberg Equality Summit on Wednesday, top government infectious disease expert Dr. Anthony Fauci again highlighted the COVID-19 pandemic's disproportionate impacts on minority populations in the United States. That's not genetic. That's our society. As Fauci told his audience, American minority groups both are more likely to hold "essential" jobs than white Americans and have higher rates of diabetes, hypertension, and other diet-related, poverty-related health issues. "There's almost a double whammy on the minority populations," said Fauci. With that in mind, Fauci again urged companies to gain representative samples of Black Americans and other nonwhite groups in late-stage vaccine tests. "We have...
    ALBANY — Gov. Andrew Cuomo said he will set up his own review board to double check any federally approved COVID-19 vaccine, citing his distrust of President Trump and calling Washington’s efforts to fast-track the drug “politicized” ahead of the November election Raising concerns over the drug’s administration in New York, Cuomo argued Thursday that a second team of handpicked “experts” must also review the vaccine’s efficacy ahead of getting the green light in the Empire State. He named nearly 20 government, labor and health officials — including Ken Raske, head of the powerful healthcare lobby Greater New York Hospital Association; Northwell Health chief Michael Dowling, who sat by the governor’s side at many coronavirus briefings throughout the pandemic’s...
    ALBANY — Gov. Andrew Cuomo said he will set up his own review board to double check any federally approved COVID-19 vaccine, citing his distrust of President Trump and calling Washington’s efforts to fast-track the drug “politicized” ahead of the November election Raising concerns over the drug’s administration in New York, Cuomo argued Thursday that a second team of handpicked “experts” must also review the vaccine’s efficacy ahead of getting the green light in the Empire State. He named nearly 20 government, labor and health officials — including Ken Raske, head of the powerful healthcare lobby Greater New York Hospital Association; Northwell Health chief Michael Dowling, who sat by the governor’s side at many coronavirus briefings throughout the pandemic’s height;...
    Savannah Rychcik September 24, 2020 0 Comments New York Gov. Andrew Cuomo (D) is not willing to put his trust into the federal government when it comes to the approval process for a COVID-19 vaccine. Cuomo revealed during his press briefing on Thursday New York will conduct its own review of a coronavirus vaccine approved by the federal government amid fears surrounding the politicization of the process. He cited a poll proving 54% of Americans say they would not take a coronavirus vaccine before the election. Cuomo noted President Donald Trump claims the the Food and Drug Administration is attempting to politicize the approval process. He suggested Trump’s political interest in the approval of a vaccine is more pressing...
    (CNN)Operation Warp Speed, the mission to develop an effective Covid-19 vaccine, seeks to deliver 300,000 doses by January 2021. According to projections from the University of Washington, by then the US death toll from the novel coronavirus will likely have reached nearly 400,000. Edgar MarcuseWhat evidence of vaccine effectiveness -- balanced by what assurance of safety -- would prompt you to seek a dose of one of these novel vaccines to protect an elderly family member or for yourself?Optimal use of these Covid-19 vaccines will depend on the confidence of the American people in the processes leading up to the vaccines' release. The Food and Drug Administration's (FDA) Biologics License Application (BLA) is the standard path to vaccine licensing. The...
    Sign up for our COVID-19 newsletter to stay up-to-date on the latest coronavirus news throughout New York City BY JULIE STEENHUYSEN The scientific head of the U.S. government program designed to speed development of COVID-19 vaccines said on Thursday he supports stricter rules to grant emergency use of new inoculations against the novel coronavirus. Speaking at a meeting with Black physicians and community leaders, Operation Warp Speed scientific lead Dr. Moncef Slaoui said he supports recommendations being drafted by the U.S. Food and Drug Administration that companies wait two months after the last administration of their vaccine before seeking emergency use authorization (EUA) of their products. Operation Warp Speed already has recommended the vaccine candidates it is supporting observe...
    By DANICA KIRKA, Associated Press LONDON (AP) — The British government says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works. The approach, called a challenge study, is risky but proponents think it may produce results faster than typical studies, which wait to see if volunteers who have been given an experimental treatment or a dummy version get sick. “We are working with partners to understand how we might collaborate on the potential development of a COVID-19 vaccine through human challenge studies,” the U.K. Department for Business, Enterprise and Industrial Strategy said in a prepared...
    Roger Sollenberger September 24, 2020 5:54PM (UTC) Sen. Thom Tillis, R-N.C., on Thursday told a virtual town hall audience that he believed the 200,000 deaths attributed to COVID-19 in the U.S. had been inflated in order to "encourage people to use social distancing." "When the final accounting is done," the actual COVID-19 death count will be lower, Tillis claimed. : The response echoes a false conspiracy theory pushed by adherents of the baseless QAnon movement: that public health officials are allegedly lying to the public about the true death count because of ulterior or possibly sinister motives. Only 6% of the reported deaths are attributable solely to COVID-19, the conspiracy theorists claim.  Tillis also embraced an extreme anti-vaccine position and appeared to welcome herd immunity as part of a strategy to get...
    LONDON – The British government says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works. The approach, called a challenge study, is risky but proponents think it may produce results faster than typical studies, which wait to see if volunteers who have been given an experimental treatment or a dummy version get sick. “We are working with partners to understand how we might collaborate on the potential development of a COVID-19 vaccine through human challenge studies,” the U.K. Department for Business, Enterprise and Industrial Strategy said in a prepared statement. “These discussions are...
    LONDON (AP) — The British government says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works. The approach, called a challenge study, is risky but proponents think it may produce results faster than typical studies, which wait to see if volunteers who have been given an experimental treatment or a dummy version get sick. “We are working with partners to understand how we might collaborate on the potential development of a COVID-19 vaccine through human challenge studies,” the U.K. Department for Business, Enterprise and Industrial Strategy said in a prepared statement. “These discussions...
    A secret group of more than a dozen experts is in charge of vetting and approving a coronavirus vaccine — or vaccines — for the American public to use. According to NBC News, the data and safety monitoring board, or DSMB, is led by pediatric infectious disease expert Dr. Richard Whitley, who was appointed by Dr. Anthony Fauci — the director of the National Institute of Allergy and Infectious Diseases, or NIAID. The DSMB will review each vaccine candidates safety and efficacy before deciding whether to allow it to enter the U.S. market. The group also is able to order a clinical trial of a drug vaccine or stop one. Experts told NBC the reason why the members identities are kept...
    As drugmakers race to develop coronavirus vaccines, a task force formed by the nation's oldest Black physicians group will be tracking the data amid fears that political considerations could overrule safety concerns, particularly when it comes to African Americans.  "This is about ensuring safety for Operation Warp Speed," said Dr. Leon McDougle, president of the National Medical Association (NMA), referring to the Trump administration's effort to accelerate the development and distribution of COVID-19 vaccines. "We're really doing this to be a source of trusted information for our physicians and our community." The NMA's task force, comprised of infectious disease and immunization experts, will be "reviewing the available data to help ensure appropriate evidence exists, and that in clinical trials diversity is...
    Scientists are calling for answers as to why the US arm of Oxford's Covid-19 vaccine trial is still on hold — two weeks after it was first paused.  AstraZeneca, the drug giant which owns the rights to the experimental jab, stopped global trials on September 8 because a British volunteer was hospitalised. She has now been discharged. Uncertainty remains about what happened to the unnamed 37-year-old because of medical confidentiality. But leaked documents claimed she developed 'transverse myelitis' — a neurological condition which left her struggling to walk.  Doctors restarted trials in the UK on September 12 after an independent safety review committee and the UK regulator, the Medicines and Healthcare Products Regulatory Agency, investigated and deemed it safe to do...
    (CNN)While nearly half of US states now report a rise in new Covid-19 cases, a leading public health official announced the majority of Americans remain susceptible to the virus. Speaking to the Senate Health Committee this week, US Centers for Disease Control and Prevention Director Dr. Robert Redfield said preliminary results on the first round of a study by the agency show more than 90% of the population is susceptible. That means more than 295 million Americans could still get infected with the virus. Why does Rand Paul think he knows better than Anthony Fauci?About 6.9 million people across the country have already contracted the illness and more than 200,000 people have died since the start of the pandemic,...
            by Andrew Trunsky  Johnson & Johnson began its final round of testing for its COVID-19 vaccine Wednesday. The study is one of the most expansive to occur so far, involving 60,000 volunteers across the United States, Argentina, Brazil, Chile, Peru, Mexico and South Africa, the Associated Press reported. The vaccine is the latest to begin its final testing phase, joining candidates developed by Moderna and Pfizer, and is the only vaccine that would be administered as a single dose. “We want to do everything we can without sacrificing safety or efficacy… to make sure that we end up with vaccines that are going to save lives,” Director of the National Institutes of Health Dr. Francis Collins said to reporters,...
    (CNN)The British government is exploring the possibility of clinical trials in which volunteers are deliberately exposed to coronavirus to test the effectiveness of vaccine candidates, the UK Department for Business, Energy, and Industrial Strategy (BEIS) revealed Wednesday in a statement. "We are working with partners to understand how we might collaborate on the potential development of a COVID-19 vaccine through human challenge studies," a government spokesperson said. "These discussions are part of our work to research ways of treating, limiting and hopefully preventing the virus so we can end the pandemic sooner," the spokesperson added. Read More In so-called "challenge trials," researchers give study subjects an experimental vaccine and then intentionally expose them to coronavirus to see if...
    WASHINGTON (Reuters) - U.S. President Donald Trump said on Wednesday he may or may not approve potentially new, more stringent standards for an emergency authorization of a COVID-19 vaccine by the U.S. Food and Drug Administration, saying such a move would appear political. The Washington Post reported on Tuesday the FDA would issue the guidance to boost transparency and public trust as health experts have become increasingly concerned the Trump administration might be interfering in the approval process. "That has to be approved by the White House. We may or may not approve it," Trump told a White House news conference. "That sounds like a political move." (Reporting by Jeff Mason and Eric Beech, writing by Phil Stewart, editing by...
    WASHINGTON -- A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the government ultimately approves.Hopes are high that answers about at least one of several candidates being tested in the U.S. could come by year's end, maybe sooner."We feel cautiously optimistic that we will be able to have a safe and effective vaccine, although there is never a guarantee of that," Dr. Anthony Fauci, infectious disease chief at the National Institutes of Health, told a Senate committee.But President Donald Trump is pushing for a faster timeline than many experts say...
    Nicole Karlis September 23, 2020 10:31PM (UTC) On Wednesday morning, leading infectious disease expert Dr. Anthony Fauci and other members of the White House coronavirus task force testified before a Senate subcommittee on the Trump administration's coronavirus response. The hearing took place amid the grim news that 200,000 American lives have now been lost to the novel coronavirus and the country leads the world in total cases, with over 6.9 million infected. Fauci, Dr. Robert Redfield, director of the U.S. Centers for Disease Control and Prevention and the assistant secretary for health at the U.S. Department of Health and Human Services, Adm. Brett Giroir, and Stephen Hahn, Commissioner Of Food And Drugs at the Food and Drug Administration (FDA), addressed...
    WASHINGTON -- A huge international study of a COVID-19 vaccine that aims to work with just one dose is getting underway as top U.S. health officials sought Wednesday to assure a skeptical Congress and public that they can trust any shots the government ultimately approves.Hopes are high that answers about at least one of several candidates being tested in the U.S. could come by year's end, maybe sooner."We feel cautiously optimistic that we will be able to have a safe and effective vaccine, although there is never a guarantee of that," Dr. Anthony Fauci, infectious disease chief at the National Institutes of Health, told a Senate committee.But President Donald Trump is pushing for a faster timeline than many experts say...
    NEW YORK (CBSNewYork) — Another COVID-19 vaccine has entered what is described as the pivotal stage before applying for Food and Drug Administration approval. It’s a very large Phase 3 trial from Johnson & Johnson. As CBS2’s Dr. Max Gomez reported Wednesday, this trial may have some advantages over other candidate vaccines. MORE: Potential AstraZeneca-Oxford COVID-19 Vaccine Suffers Setback, Trial Paused It proposes to enroll 60,000 volunteers in placebo-controlled testing. That’s about twice as large as other companies’ trials, although Pfizer recently expanded its trial to 44,000 volunteers. While 60,000 is a massive undertaking, the Johnson & Johnson vaccine does have a couple of theoretical advantages over other vaccines. CORONAVIRUS PANDEMIC Tri-State Coronavirus Travel Advisory Quarantine List Resources, Hotlines, Unemployment...
    STANFORD, Calif. (KGO) -- The Bay Area will soon be the site of expanding clinical trials of potential COVID-19 vaccines. Stanford has announced that it will now begin recruiting for at least one new trial, with others possibly to follow.With the nation's attention focused on the race to develop a COVID-19 vaccine, researchers at Stanford are now joining the effort to produce reliable and accurate data to move the most promising candidates forward.RELATED: Pres. Trump says US to have 100M COVID-19 vaccine doses before 2021, despite contradictions from health expertsFirst up is a trial vaccine from Johnson & Johnson. Investigator Dr. Phil Grant says the formula relies on a disabled virus to carry instructions for creating anti-COVID proteins into the...
    STANFORD, Calif. (KGO) -- The Bay Area will soon be the site of expanding clinical trials of potential COVID-19 vaccines. Stanford has announced that it will now begin recruiting for at least one new trial, with others possibly to follow.With the nation's attention focused on the race to develop a COVID-19 vaccine, researchers at Stanford are now joining the effort to produce reliable and accurate data to move the most promising candidates forward.RELATED: Pres. Trump says US to have 100M COVID-19 vaccine doses before 2021, despite contradictions from health expertsFirst up is a trial vaccine from Johnson & Johnson. Investigator Dr. Phil Grant says the formula relies on a disabled virus to carry instructions for creating anti-COVID proteins into the...
    Savannah Rychcik September 23, 2020 0 Comments Dr. Anthony Fauci is reassuring Americans it is not possible to contract the coronavirus through a vaccine. During Wednesday’s Senate Committee on Health, Education, Labor, and Pensions hearing, Sen. Lamar Alexander (R-Tenn.) pressed Fauci on whether receiving a shot of the coronavirus vaccine will give him the coronavirus. “Absolutely not. That would be impossible,” Fauci said. He reiterated the risk of contracting the coronavirus through a vaccine “does not exist.” Fauci went on to note the effectiveness of the coronavirus vaccine is unknown as well as how long it will last. Watch his comments below (starting at 2:56:00): “We will find out the answer to those questions through the clinical trials and the...
    Reuters September 23, 2020 0 Comments A top U.S. health official told a U.S. Senate committee on Wednesday that he expects COVID-19 vaccinations to take place over many months and that most Americans could be vaccinated by July of 2021 at the latest. U.S. Centers for Disease Control and Prevention head Robert Redfield said he expects there to be about 700 million doses of vaccines available by late March or April, enough for 350 million people. “I think that’s going to take us April, May, June, you know, possibly July, to get the entire American public completely vaccinated,” Redfield told the U.S. Senate Health, Education, Labor and Pensions Committee. Redfield, U.S. Food and Drug Administration head Stephen Hahn, U.S....
    As President Trump continues to push the idea of herd immunity as a key approach to battling the coronavirus pandemic, the director of the Centers for Disease Control and Prevention said Wednesday that the vast majority of Americans are still at risk of contracting the virus, citing preliminary data from a CDC study.  "The preliminary results in the first round show that a majority of our nation, more than 90% of the population, remains susceptible," CDC Director Dr. Robert Redfield said while testifying at a Senate hearing Wednesday. "A majority of Americans are still susceptible to this virus."  Redfield said the CDC is currently conducting a "very large" study in an effort to determine how the country has been affected...
    WASHINGTON — Food and Drug Administration Commissioner Stephen Hahn and infectious disease expert Dr. Anthony Fauci on Wednesday said the public should trust the COVID-19 vaccine approval process. Hahn, whose agency would approve a vaccine, and Fauci told a Senate committee they would take a vaccine themselves — after Democratic presidential candidate Joe Biden and running mate Sen. Kamala Harris (D-Calif.) said President Trump may corrupt the science. Fauci, the longtime director of the National Institute of Allergy and Infectious Diseases and a White House coronavirus task force member, vouched for vaccine production. “The rapidity of where we are right now is a reflection of the technological advances in vaccine platform technology, as well as the risks that were...
    WASHINGTON — Food and Drug Administration Commissioner Stephen Hahn and infectious disease expert Dr. Anthony Fauci on Wednesday said the public should trust the COVID-19 vaccine approval process. Hahn, whose agency would approve a vaccine, and Fauci told a Senate committee they would take a vaccine themselves — after Democratic presidential candidate Joe Biden and running mate Sen. Kamala Harris (D-Calif.) said President Trump may corrupt the science. Fauci, the longtime director of the National Institute of Allergy and Infectious Diseases and a White House coronavirus task force member, vouched for vaccine production. “The rapidity of where we are right now is a reflection of the technological advances in vaccine platform technology, as well as the risks that were taken...
    Sen. Bob Casey (D-PA) asked a panel of health officials, including Dr. Anthony Fauci, to commit to taking the upcoming Covid-19 vaccine in an effort to raise the public’s confidence. During a Senate hearing on Wednesday, Casey said, “One of the most important challenges we face in developing and then distributing and administering a safe and effective vaccine is public confidence.” “As a way to demonstrate faith and the integrity of both the approval process, and to assure the American public that vaccines are safe, I would ask the other three members of our panel if they will commit to receiving the Covid-19 vaccine in public view once one becomes available and is authorized and approved by the FDA,” he...
    By The Associated Press UNITED NATIONS (AP) — The Latest from the U.N. General Assembly (all times EDT): 9 a.m. The chairman of Bosnia’s three-member presidency is urging the world’s nations at their first virtual U.N. meeting to make a coronavirus vaccine available to all of mankind. Sefik Dzaferovic said in his pre-recorded speech to the high-level General Assembly session that the past few years have seen a “crisis of multilateralism” at international organizations including the United Nations. He said the 193-member world body has become an object of dispute but that the COVID-19 pandemic has shown that the U.N. has extraordinary significance in today’s globalized world. “The pandemic has shown that the largest problems of today can no longer...
    TANZANIA – The Latest from the U.N. General Assembly (all times EDT): 9 a.m. The chairman of Bosnia’s three-member presidency is urging the world’s nations at their first virtual U.N. meeting to make a coronavirus vaccine available to all of mankind. Sefik Dzaferovic said in his pre-recorded speech to the high-level General Assembly session that the past few years have seen a “crisis of multilateralism” at international organizations including the United Nations. He said the 193-member world body has become an object of dispute but that the COVID-19 pandemic has shown that the U.N. has extraordinary significance in today’s globalized world. “The pandemic has shown that the largest problems of today can no longer be solved...
    Johnson & Johnson began its final round of testing for its COVID-19 vaccine Wednesday. The study is one of the most expansive to occur so far, involving 60,000 volunteers across the United States, Argentina, Brazil, Chile, Peru, Mexico and South Africa, the Associated Press reported. The vaccine is the latest to begin its final testing phase, joining candidates developed by Moderna and Pfizer, and is the only vaccine that would be administered as a single dose. “We want to do everything we can without sacrificing safety or efficacy… to make sure that we end up with vaccines that are going to save lives,” Director of the National Institutes of Health Dr. Francis Collins said to reporters, according to AP. President...
    President Trump on Wednesday hailed the “Big news” that Johnson & Johnson has reportedly entered final clinical trials for a coronavirus vaccine that would require one shot. “Big news. Numerous great companies are seeing fantastic results. @FDA must move quickly!,” the president wrote on Twitter, linking to a New York Times report on the development. The Times article said the drugmaker entered the final phase on Monday and will be the largest – enrolling 60,000 participants – of other competitors’ efforts to develop a vaccine. The vaccine developed by Johnson & Johnson doesn’t need to be stored at subzero temperatures and may need one dose instead of two. “It would be fabulous if we had something at a single dose,”...
    The Food and Drug Administration is expected to issue new rules for an emergency use authorization for a coronavirus vaccine – and they will make it very unlikely that an inoculation will be cleared before Election Day, according to a report. The FDA is issuing the guidance to increase transparency and public trust amid polls about the politicization of the process to roll out a vaccine, according to the Washington Post. The Pew Research Center has reported that the percentage of Americans who said they would get the shot if it were available now has dropped to just over 50 percent from 72 percent in May, according to the paper. New rules are expected to be far stricter than those...
    Johnson & Johnson is starting a huge study to test if a single-dose COVID-19 vaccine can protect people against the coronavirus. The study, launching Wednesday, will be one of the world's largest coronavirus vaccine studies so far, testing the  in 60,000 volunteers in the U.S., South Africa, Argentina, Brazil, Chile, Colombia, Mexico and Peru. A handful of other vaccines in the U.S. — including shots made by Moderna and Pfizer — as well as drug developers in other countries are already in final-stage testing. Hopes are high that answers about at least one candidate being tested in the U.S. could come by year's end, maybe sooner.  Pfizer and its partner BioNTech may be the first to learn if their vaccine...
    Over the last several weeks, President Donald Trump has approached the White House press podium with one resounding message: The coronavirus vaccine is just around the corner and it will soon make its way to Americans across the country. But behind closed doors Trump’s closest advisers, including those officials working on the White House coronavirus task force, are increasingly concerned about public confidence in the vaccine process. Now, White House officials are leaning on the nation’s governors to help promote the vaccine’s safety and efficacy. On a private call with governors Monday, Vice President Mike Pence and other top coronavirus task force officials—including Dr. Anthony Fauci and Director of the Centers for Disease Control and Prevention Robert Redfield—aired their fears...
    (CNN)More than 200,000 Americans have lost their lives to Covid-19 since the start of the pandemic, and the country is now transitioning into a new season with worrisome trends.The devastating death toll comes ahead of what experts caution could be a complicated flu season. In the next three months, another 150,000 people could lose their lives from Covid-19, according to a projection by the University of Washington's Institute for Health Metrics and Evaluation (IHME)."We're entering into the fall and into the winter, and that means there's going to be more indoor things than outdoor things," Dr. Anthony Fauci said Tuesday during the Atlantic Festival. "Going into that situation, I would like to have seen the baseline of where we are...
    (CNN)More than 80 years ago, the American salesman extraordinaire, Elmer Wheeler, introduced his "Five Wheeler Points" to help his brethren boost sales of whatever it was they were selling. The first Point, later immortalized by an episode of Seinfeld , was this: "don't sell the steak -- sell the sizzle." JUST WATCHEDGiroir: We do not have a safe, effective vaccine yetReplayMore Videos ...MUST WATCHGiroir: We do not have a safe, effective vaccine yet 03:38This adage seems to have been adopted by the some in the Trump administration as they still, seven months in, try to find their footing on the federal response to the Covid-19 pandemic. We have seen a lot of sizzle -- lots of happy talk about...
    NEW YORK - As the U.N. General Assembly annual debate got under way Tuesday, combating and eliminating the coronavirus pandemic was the foremost preoccupation of the world's major powers.   Global leaders are meeting virtually this year due to COVID-19, the disease caused by the coronavirus. Confirmed coronavirus cases worldwide have surpassed 31 million, with more than 960,000 deaths, according to the Johns Hopkins Coronavirus Resource Center, which tracks the data.    A reporter with the Xinhua Press Agency watches as President Xi Jinping is seen on a video screen remotely addressing the 75th session of the United Nations General Assembly, Sept. 22, 2020, at U.N. headquarters.From China, the country where the virus is believed to have originated, President...
    The Food and Drug Administration is expected to announce new standards for approving a coronavirus vaccine in an apparent attempt to shore up confidence with the American people, according to a report. The Washington Post reported on Tuesday that two individuals familiar with the issue said the FDA will ask manufacturers to follow clinical trial participants for at least two months in order to obtain an emergency authorization. Additionally, trials will have to show evidence surrounding more severe cases and older people, making it unlikely that a vaccine will be finished before the 2020 presidential election. Moderna and Pfizer each started their trials in July. The enrollment process took about a month with a second round of shots being administered after three or four...
    Bradley Cortright September 22, 2020 0 Comments Chelsea Clinton, the daughter of the former Democratic presidential nominee Hillary Clinton, says he holds President Donald Trump entirely responsible for the 200,000 deaths from COVID-19.  During an appearance on ABC’s “The View” on Tuesday, Chelsea was asked, “How much do you blame [Trump] and his response? Or the lack thereof?” “I blame him pretty fundamentally,” she responded. “I think it’s unconscionable that he lied to the American public about Covid. That he’s continued to lie to the American people. That he has such a blatant disregard for public health.” She alluded to a portion of journalist Bob Woodward’s new book “Rage” that shows Trump knew far more about COVID-19 and the threat it posed as...
    Savannah Rychcik September 22, 2020 0 Comments While President Donald Trump suggests a coronavirus vaccine could be ready before the election, some Americans are not willing to be the first to receive it. According to an Axios-Ipsos poll, Americans’ eagerness to try the first generation of a coronavirus vaccine has continued to decline over the past month. Several Americans feel the risk involved with receiving the first generation of the vaccine is too high and want to see how others do with it. Only 13% of Americans say they would want to try it immediately. Six in 10 Americans are not willing to take the vaccine as soon as it becomes available, which is an increase...
    Who will get the approved vaccine first? Breaking news in the race for a COVID-19 vaccine. The federal government has just released their “playbook” for distributing a vaccine once available.     Watch THE DR. OZ SHOW, weekdays at 3 p.m. on CBS 62. Related
    UNITED NATIONS (Reuters) - Turkey's President Tayyip Erdogan said in an address to the United Nations on Tuesday any future COVID-19 vaccine should be universally available, regardless of where it is produced. "I am calling from here once again for the procurement of medical equipment and medicine, and vaccine efforts not to be made into a topic of competition," Erdogan said in a video address to the U.N. General Assembly, which is holding a virtual meeting because of the global coronavirus pandemic. "No matter what country they are produced in, vaccines that are made ready to be administered should be presented to the common use of humanity," he said. (Reporting by Tuvan Gumrukcu; Editing by Jonathan Spicer) Copyright 2020 Thomson...
    Why do children appear to fight off COVID-19 more effectively than adults? A new study published Tuesday on the immune response by children and adults to COVID-19, the disease caused by SARS-CoV-2, has important implications for vaccines and drugs being developed to curb the novel coronavirus, according to the researchers. The study in Science Translational Medicine, an online journal that publishes research at the intersection of science, engineering and medicine, was conducted by scientists at Albert Einstein College of Medicine, the Children’s Hospital at Montefiore, and Yale University. “Our findings suggest that children with COVID-19 do better than adults because their stronger innate immunity protects them,” co-senior author Betsy Herold, chief of infectious diseases and vice chair for...
    By Polina Ivanova and Anthony Boadle MOSCOW/BRASILIA (Reuters) - Russia is so confident in its COVID-19 vaccine that it will shoulder some of the legal liability should anything go wrong, rather than requiring buyers to take on the full risk, the head of the state fund bankrolling the project told Reuters. The decision leaves the vaccine's state-backed developers open to potentially costly compensation claims should there be any unexpected side-effects. It is something many vaccine-makers have sought to avoid, by asking for full indemnity - complete protection from liability claims - from nations they sell to. The approach is different from many places in the world. In the United States, for example, liability for COVID-19 vaccines has been shifted fully...
    By Sangmi Cha SEOUL (Reuters) - South Korea suspended free flu shots on Tuesday after reports of problems in storing the vaccinations during transportation, disrupting plans to pre-emptively ease the burden on a healthcare system already strained by coronavirus outbreaks. The country, which has seen a spike in COVID-19 cases since August, planned to procure 20% more flu vaccines for the winter than the previous year to jab 30 million people. It had planned to start free inoculation on Tuesday for some 19 million eligible people. The head of South Korea's disease prevention agency said on Tuesday that some doses of the vaccine, which need to be refrigerated, had been exposed to room temperature while being transported to a medical...
    NEW YORK (CBSNewYork) – Getting a flu shot is more important than ever this year, with the coronavirus pandemic still raging. Yet, misinformation about flu vaccines continues to spread. CBS2’s Dr. Max Gomez dispels the top flu shot myths. Doctors fear a “twin-demic” this fall and winter – an overlap of the flu and COVID-19. They have very similar early symptoms, but their treatment is much different. Plus, the flu can make COVID much worse – and you can get both at the same time. That’s why the flu shot is critical this year. RELATED STORY: Health Experts: Demand For Flu Shots Is Higher Than Expected, So Public Urged To Get One Sooner Rather Than Later The most prevalent flu...
    SAN ANTONIO – Screening for another COVID19 vaccination trial is beginning in San Antonio Monday. Clinical Trials of Texas is the lab conducting the study. Doctors there say that there is no way participants will become infected by taking the vaccine. About two months ago, Christopher Sandles and his wife decided to participate in a COVID-19 vaccine trial at Clinical Trials of Texas. Now that another one is getting ready to begin in a few days, he’s encouraging others to do the same. “First of all, we just need to be brave… When I was hearing we didn’t have enough individuals of color that were participating in some of the vaccine studies, I kind of saw it as it is...
    BOSTON (CBS) — Vivian Wilt is one of 30,000 people volunteering to test a coronavirus vaccine in a human challenge trial. The concept is controversial because it deliberately infects people with coronavirus, but one organization says it will lead to a cure faster than traditional vaccine development. Wilt, a 23-year-old Northeastern University student, wants to be a doctor to help people. As for her own health, she told WBZ-TV she’s not afraid of getting sick because the odds of anyone in her demographic dying is in her favor. She signed up with 1Day Sooner, an advocacy group for COVID-19 human challenge trials. If they go forward, participants would be given one of the vaccines being studied or a placebo then...
    A new study from Cleveland Clinic found getting vaccinated for the flu does not increase your risk of contracting COVID-19 or your chances of complications or death from the disease. The study, published in the Journal of Clinical and Translational Science, also revealed the seasonal flu vaccine is an important tool to protect your health during the upcoming "twindemic" —the collision of the flu and COVID-19. According to Science Magazine, scientists compared 13,000 patients who tested for COVID-19 at Cleveland Clinic and found those who had the 2019 vaccine had no variance in incidence or severity than the patients who were not vaccinated. "Our findings suggest that we should proceed as usual with our vaccination strategy from global influenza this...
    Bill Gates says he believes there will be a coronavirus vaccine approved by the US Food and Drug Administration (FDA) by early 2021. In an interview with Fortune, the Microsoft co-founder says there is a new level of collaboration among drugmakers that could see an immunization receive an emergency use authorization license in the next few months. 'The likelihood is that at least two, three, or four [vaccines] will probably prove to be both safe and efficacious,' he said. However, anti-vaxx groups fear an inoculation will lead to mandatory jabs while other Americans are skeptical that the FDA is under political pressure to authorize a vaccine before the November 3 presidential election. Gates says it will depend on how many...
    WASHINGTON -- A poll released Sunday by ABC News/Ipsos shows the majority of Americans do not trust President Donald Trump to confirm the safety of a potential COVID-19 vaccine.A total of 69 percent of people surveyed did not trust the president to vouch for the safety of a vaccine. Sixteen percent of those said their confidence level was "not so much;" while 53 percent said it was "none at all."Only 9 percent of respondents reported having a great deal of confidence in Trump, with another 18 percent having a good amount of confidence.Democratic presidential nominee Joe Biden performed better than Trump on the question of confirming a vaccine's safety and effectiveness, but still received net negative results, with 41% expressing...
    (Reuters) - VBI Vaccines Inc said on Monday it had entered into an agreement with Canada to develop a potential vaccine for COVID-19 by 2022 through mid-stage trials conducted exclusively in the country. Canada will contribute around 75% of the U.S.-based company's development costs and C$55.9 million ($42.2 million) for the project. VBI Vaccines said last month that together with the National Research Council Canada it was investigating the vaccine candidate, VBI-2900, in preclinical trials. As per the agreement, signed last week, the company's Ottawa-based unit is obligated to complete the vaccine development in or before the first quarter of 2022. There are currently no approved vaccines for COVID-19, but around 38 vaccines are being tested in humans around the...
    A health worker injects a person during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida, on Wednesday, Sept. 9, 2020.Eva Marie Uzcategui | Bloomberg | Getty Images As trust in federal health agencies has withered over the last few months, a group of Black physicians has been working on an antidote: creating their own expert task force to independently vet regulators' decisions about Covid-19 drugs and vaccines as well as government recommendations for curbing the pandemic. Organized by the National Medical Association — founded in 1895 as an answer to racist professional societies excluding Black doctors — the committee is meant to safeguard against any unscientific guidance from the Centers for Disease Control and Prevention and...
    By Sangameswaran S (Reuters) - The death toll from the spread of coronavirus in the United States was approaching over 200,000 lives on Monday, more than double the number of fatalities in India, the country reporting the second-highest number of cases in the world. The United States, on a weekly average, is now losing about 800 lives each day to the virus, according to a Reuters tally. That is down from a peak of 2,806 daily deaths recorded on April 15. (Graphic: https://tmsnrt.rs/2ZH76z6) During the early months of the pandemic, 200,000 deaths was regarded by many as the maximum number of lives likely to be lost in the United States to the virus. Earlier this month, U.S. President Donald Trump...
    Jake Johnson September 21, 2020 7:09AM (UTC) This article originally appeared at Common Dreams. It is licensed under a Creative Commons Attribution-Share Alike 3.0 License. Feel free to republish and share widely. Insisting during a town hall Tuesday night that COVID-19 will simply disappear on its own — echoing a baseless claim he also made in February, March, April, May, June, July, and August — President Donald Trump touted a so-called "herd immunity" approach to the pandemic that public health experts warn would lead to hundreds of millions of new coronavirus infections and millions of additional deaths. "We're gonna be OK. And it is going away," Trump told ABC's George Stephanopoulos. "And it's probably gonna go away now a lot faster with the...
    NEW YORK CITY (WABC) -- In this episode of Up Close, Mayor Bill de Blasio decides that there have been too many problems to start full in-person learning for the New York City school system.The school year begins on September 21, with a phased reopening to in-person learning.Grades 3-k, pre-k and special education kids in district 75 will start on September 21, while Kindergarten through 5th-grade returns on September 29, and high school starts October 1.The United Federation of Teachers President Michael Mulgrew discusses the new timeline and what it took to change the Mayor's mind.Also, On September 2, the U.S. Centers for Disease Control and Prevention Director, Robert Redfield, said states could get vaccines by November 1, coincidentally two...
    The fact that there is so much diversity in the production of vaccines is an advantage, since immunity is different according to the population group; for example, the immune response is not the same in children and the elderly as in adults. Additionally, having multiple vaccines will ensure that we have global supplies. And who will get the vaccine first? The logical thing is to think that people with a depressed immune system and people over 65, that is, those most at risk of serious complications, should be in the front row, as well as health personnel. The WHO, for its part, suggests that countries receive doses proportional to their populations. But a group of 19...
    (Reuters) - AstraZeneca Plc said on Saturday that its COVID-19 vaccine trial in the United States is still on hold. AstraZeneca on Saturday published a document https://bit.ly/2FNcqu7 describing details of how the COVID-19 vaccine trial was being carried out, which was first reported by the New York Times. (Reporting by Rama Venkat in Bengaluru; Editing by Michael Perry) Copyright 2020 Thomson Reuters.
    1. Supreme Court Justice Ruth Bader Ginsburg died on Friday at age 87, the court announced. She died of metastatic pancreatic cancer, after previously beating cancer four times. Ginsburg was appointed to the Supreme Court in 1993, the second-ever female justice, and was well known for championing gender equality, abortion rights, affirmative action, and other progressive causes. She was a part of the liberal wing of the Supreme Court; with her seat vacant, President Trump will have the opportunity to further solidify the court’s conservative majority. Days before Ginsburg’s death, she said “My most fervent wish is that I will not be replaced until a new president is installed.” Senate Majority Leader Mitch McConnell (R-Ky.) said “Trump’s nominee will...
    President Donald Trump says we are on track to start delivering and distributing a COVID-19 vaccine sometime in October. U.S. Centers for Disease Control and Prevention Director Dr. Robert Redfield says the vaccine won’t be widely available until the second or third quarter of next year. Who’s right? Scientists side with Redfield. But the dispute comes at a time of growing worry about whether political pressure from the White House could influence regulators — and erode public confidence in vaccines. To help you navigate the political thicket and understand what’s really happening, here’s a guide to vaccine approval, the likely timeline and the potential consequences, based on the perspectives of key researchers and regulators. There’s unlikely to be a vaccine...
    LOS ANGELES (KABC) -- Can wearing glasses help protect you from COVID-19?When is the best time to get a flu shot this year?Can coronavirus particles be carried through secondhand smoke?These were some of the questions addressed by Dr. Anthony Cardillo in his latest Ask the Doctor session with Eyewitness News.Cardillo is an ER specialist and CEO of Mend Urgent Care in the Los Angeles area.Q: If you wear glasses, could you be at lower risk for COVID-19?Cardillo says a recent study out of China found a lower rate of COVID-19 hospitalizations among people who wear glasses.The study noted that about one-third of China's population is nearsighted and wears glasses. So it would make sense that about one-third of the patients...
    TAKOMA PARK, Md. (AP) — In front of baskets of tomatoes and peppers, near a sizzling burrito grill, the “promotoras” stop masked shoppers at a busy Latino farmers market: Want to test a COVID-19 vaccine? Aided by Spanish-speaking “health promoters” and Black pastors, a stepped-up effort is underway around the U.S. to recruit minorities to ensure potential vaccines against the scourge are tested in the populations most ravaged by the virus. Many thousands of volunteers from minority groups are needed for huge clinical trials underway or about to begin. Scientists say a diverse group of test subjects is vital to determining whether a vaccine is safe and effective for everyone and instilling broad public confidence in the shots once they...
    President Donald Trump announced Friday that a COVID-19 vaccine will be distributed within 24 hours of completion of phase 3 trials and FDA approval, with all Americans having access to the vaccine by April, according to the Daily Caller. Speed has been the priority in the pursuit of a vaccine to provide relief to the country from the pandemic, as evidenced by the name of the initiative: Operation Warp Speed. From the Daily Caller:"Since January, America's brilliant doctors and scientists have been working been working around the clock, the best medical minds in the world by far and the vaccines are going through the gold standard of clinical trials, very heavy emphasis placed on safety," Trump told reporters at...
    Getty Centers for Disease Control and Prevention Director Dr. Robert Redfield appears during a Senate Appropriations subcommittee hearing on a review of Coronavirus Response Efforts on Capitol Hill, on September 16, 2020, in Washington, DC. After abandoning its original stance on who should be tested for COVID-19 last month, the Center for Disease Control did a 360 Friday and reverted back to their original recommendation that people who have been within six feet of an infected person for at least 15 minutes should get be tested for COVID-19. The updated guidance comes on the heels of the CDC’s advice in late August that said even if a person had been in close contact with a person was infected...
    WASHINGTON -- President Donald Trump announced Friday that the U.S. will have 100 million doses of an approved coronavirus vaccine manufactured by the end of 2020."As soon as a vaccine is approved, my administration will deliver it to the American people immediately. Distribution will begin 24 hours after notice," Trump said during the Friday news conference.He said the government will have enough vaccines to distribute to every American by April.The president's recent statements on vaccine readiness contradict the government's top health experts.Dr. Robert Redfield, head of the Centers for Disease Control and Prevention, had predicted that a vaccine would be available to the general public sometime in the spring or summer of 2021, a statement Trump rebutted by calling Redfield...